NDTP
NDT Pharmaceuticals Inc., a biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury. The company is based in Vienna, Virginia.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q4 | 0.00 | $0 | — |
| 2025 Q3 | 0.00 | $0 | -$190 |
| 2025 Q2 | 0.00 | $0 | — |
| 2025 Q1 | 0.00 | $0 | — |
| 2024 Q4 | 0.00 | $0 | — |
| 2024 Q3 | 0.00 | $0 | — |
| 2024 Q2 | -0.00 | $0 | -$7,700 |
| 2024 Q1 | 0.00 | $0 | -$1,089 |